PT966283E - Produtos farmaceuticos para cura e prevencao de doencas resultantes de lesao das celulas do endotelio vascular - Google Patents
Produtos farmaceuticos para cura e prevencao de doencas resultantes de lesao das celulas do endotelio vascularInfo
- Publication number
- PT966283E PT966283E PT97933813T PT97933813T PT966283E PT 966283 E PT966283 E PT 966283E PT 97933813 T PT97933813 T PT 97933813T PT 97933813 T PT97933813 T PT 97933813T PT 966283 E PT966283 E PT 966283E
- Authority
- PT
- Portugal
- Prior art keywords
- pct
- lesion
- cure
- prevention
- pharmaceutical products
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 210000003989 endothelium vascular Anatomy 0.000 title 1
- 230000003902 lesion Effects 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 229940127557 pharmaceutical product Drugs 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 210000002889 endothelial cell Anatomy 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 150000002443 hydroxylamines Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU9602204A HUP9602204D0 (en) | 1996-08-09 | 1996-08-09 | Pharmaceutical compositions for treating diseases connected with the disfunction of the vascular endothelial cells |
HU9701349A HUP9701349A1 (hu) | 1997-08-04 | 1997-08-04 | Gyógyászati készítmények a vaszkuláris endoteliális sejtek rendellenes működésével összefüggő betegségek gyógyítására vagy megelőzésére |
Publications (1)
Publication Number | Publication Date |
---|---|
PT966283E true PT966283E (pt) | 2006-08-31 |
Family
ID=90014231
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT97933813T PT966283E (pt) | 1996-08-09 | 1997-08-06 | Produtos farmaceuticos para cura e prevencao de doencas resultantes de lesao das celulas do endotelio vascular |
Country Status (20)
Country | Link |
---|---|
US (1) | US6143741A (pt) |
EP (1) | EP0966283B1 (pt) |
JP (1) | JP2001504446A (pt) |
AT (1) | ATE329592T1 (pt) |
AU (1) | AU739614B2 (pt) |
BG (1) | BG64456B1 (pt) |
CA (1) | CA2262997C (pt) |
CZ (1) | CZ298542B6 (pt) |
DE (1) | DE69736130T2 (pt) |
DK (1) | DK0966283T3 (pt) |
EE (1) | EE04044B1 (pt) |
ES (1) | ES2267148T3 (pt) |
HK (1) | HK1025506A1 (pt) |
IL (1) | IL128256A (pt) |
NO (1) | NO325109B1 (pt) |
PT (1) | PT966283E (pt) |
RS (1) | RS49719B (pt) |
SK (1) | SK284301B6 (pt) |
UA (1) | UA64716C2 (pt) |
WO (1) | WO1998006400A2 (pt) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU9701081D0 (en) | 1997-06-23 | 1997-08-28 | Gene Research Lab Inc N | Pharmaceutical composition of antitumoral activity |
HU226617B1 (en) * | 1998-12-14 | 2009-04-28 | Cytrx Corp | Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, and pharmaceutical composition containing the compound as active ingredient |
HUP9900475D0 (en) * | 1999-02-26 | 1999-04-28 | Biorex Kutato Fejlesztoe Kft | O-(3-piperidino-2-hydroxy-1-propyl)-hiyroximic acid-halogenid derivative, it's use for treating insulin resistance, and pharmaceutical compositions containing them as active component |
WO2003057664A1 (en) | 2002-01-11 | 2003-07-17 | Biorex Kutató És Fejlesztö Rt. | Carboxamidine derivatives and their use in the treatment of vascular diseases |
HUP0303584A3 (en) | 2003-10-30 | 2009-12-28 | Cytrx Corp | Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases |
TW200831479A (en) * | 2006-09-26 | 2008-08-01 | Cytrx Corp | Pharmaceutical compositions and methods for treating diseases |
MX2009005798A (es) * | 2006-12-01 | 2009-08-12 | Cytrx Corp | Recuperacion de apoplejia. |
TW200901958A (en) * | 2007-05-04 | 2009-01-16 | Cytrx Corp | Diabetic wound healing |
JP5429865B2 (ja) * | 2009-09-15 | 2014-02-26 | 学校法人日本大学 | 生体外創傷治癒試験用用具または創傷作製方法 |
HUP1100535A2 (en) * | 2011-09-26 | 2013-04-29 | Bracelia Invest Ltd | Pharmaceutical composition for enhancement of stem cell treatment |
US9802927B2 (en) | 2015-06-10 | 2017-10-31 | Denali Therapeutics, Inc. | Oxadiazine compounds and methods of use thereof |
MX2023005954A (es) | 2020-11-19 | 2023-09-04 | Zevra Denmark As | Procesos para preparar citrato de arimoclomol e intermediarios del mismo. |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4187220A (en) * | 1977-08-30 | 1980-02-05 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. | New O-(3-amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
HU207988B (en) * | 1988-10-20 | 1993-07-28 | Biorex Kutato Fejlesztoe Kft | Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components |
GB9017351D0 (en) * | 1990-08-08 | 1990-09-19 | Wellcome Found | Medicaments for treatment of atherosclerosis |
WO1995030649A1 (en) * | 1994-05-06 | 1995-11-16 | Biorex Kutató És Fejleszto^' Rt. | Novel hydroximic acid derivatives, pharmaceutical compositions containing them and process for preparing same |
HU218480B (hu) * | 1995-06-15 | 2000-09-28 | BIOREX Kutató és Fejlesztő Rt. | Hidroxilaminszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények |
HU222994B1 (hu) * | 1995-11-02 | 2004-01-28 | BIOREX Kutató és Fejlesztő Rt. | Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására |
-
1997
- 1997-06-08 UA UA99020697A patent/UA64716C2/uk unknown
- 1997-08-06 PT PT97933813T patent/PT966283E/pt unknown
- 1997-08-06 RS YUP-51/99A patent/RS49719B/sr unknown
- 1997-08-06 SK SK154-99A patent/SK284301B6/sk not_active IP Right Cessation
- 1997-08-06 WO PCT/HU1997/000044 patent/WO1998006400A2/en active IP Right Grant
- 1997-08-06 AT AT97933813T patent/ATE329592T1/de active
- 1997-08-06 CA CA002262997A patent/CA2262997C/en not_active Expired - Fee Related
- 1997-08-06 DK DK97933813T patent/DK0966283T3/da active
- 1997-08-06 AU AU37049/97A patent/AU739614B2/en not_active Ceased
- 1997-08-06 IL IL12825697A patent/IL128256A/en not_active IP Right Cessation
- 1997-08-06 ES ES97933813T patent/ES2267148T3/es not_active Expired - Lifetime
- 1997-08-06 EE EEP199900044A patent/EE04044B1/xx not_active IP Right Cessation
- 1997-08-06 CZ CZ0043599A patent/CZ298542B6/cs not_active IP Right Cessation
- 1997-08-06 JP JP50952798A patent/JP2001504446A/ja not_active Ceased
- 1997-08-06 US US09/230,941 patent/US6143741A/en not_active Expired - Fee Related
- 1997-08-06 DE DE69736130T patent/DE69736130T2/de not_active Expired - Lifetime
- 1997-08-06 EP EP97933813A patent/EP0966283B1/en not_active Expired - Lifetime
-
1999
- 1999-02-05 NO NO19990547A patent/NO325109B1/no not_active IP Right Cessation
- 1999-02-22 BG BG103194A patent/BG64456B1/bg unknown
-
2000
- 2000-06-28 HK HK00103903A patent/HK1025506A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
BG103194A (en) | 1999-09-30 |
DE69736130T2 (de) | 2007-01-04 |
BG64456B1 (bg) | 2005-03-31 |
EP0966283B1 (en) | 2006-06-14 |
NO990547D0 (no) | 1999-02-05 |
AU739614B2 (en) | 2001-10-18 |
CA2262997A1 (en) | 1998-02-19 |
UA64716C2 (en) | 2004-03-15 |
JP2001504446A (ja) | 2001-04-03 |
IL128256A (en) | 2004-05-12 |
ES2267148T3 (es) | 2007-03-01 |
NO325109B1 (no) | 2008-02-04 |
SK284301B6 (sk) | 2005-01-03 |
CA2262997C (en) | 2008-07-29 |
CZ298542B6 (cs) | 2007-10-31 |
HK1025506A1 (en) | 2000-11-17 |
EE9900044A (et) | 1999-08-16 |
NO990547L (no) | 1999-03-25 |
WO1998006400A3 (en) | 1998-03-26 |
RS49719B (sr) | 2007-12-31 |
SK15499A3 (en) | 2000-02-14 |
WO1998006400A2 (en) | 1998-02-19 |
YU5199A (sh) | 2000-10-30 |
EE04044B1 (et) | 2003-06-16 |
US6143741A (en) | 2000-11-07 |
DK0966283T3 (da) | 2006-10-09 |
AU3704997A (en) | 1998-03-06 |
IL128256A0 (en) | 2000-02-17 |
CZ43599A3 (cs) | 1999-07-14 |
DE69736130D1 (de) | 2006-07-27 |
EP0966283A2 (en) | 1999-12-29 |
ATE329592T1 (de) | 2006-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE205086T1 (de) | Verwendung von dem chelatbildner clioquinol zur herstellung eines arzneimittelszur behandlung von alzheimerschen krankheit | |
WO2000056303A3 (en) | Treatment of immune diseases | |
NO953542L (no) | Fremgangsmåte for inhibering av bentap med 3,4-diarylkroman | |
PT966283E (pt) | Produtos farmaceuticos para cura e prevencao de doencas resultantes de lesao das celulas do endotelio vascular | |
AR020001A1 (es) | COMPUESTOS ACTIVADORES DE hPPARGAMMA Y hPPARALFA, COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN, METODO PARA EL TRATAMIENTO Y/O PREVENCION DE UNAENFERMEDAD MEDIADA POR LOS MISMOS, Y SU USO PARA LA ELABORACION DE UN MEDICAMENTO | |
DE69434598D1 (de) | Verwendung von Paclitaxel und seinen Derivaten zur Herstellung eines Medikaments für die Behandlung von Restenose | |
NO972980D0 (no) | Anvendelse av nebivolol som et anti-aterogent middel | |
ES2045182T3 (es) | Substancias fisiologicamente activas, un proceso para la preparacion de las mismas y composiciones farmaceuticas que las contienen. | |
ES2157005T3 (es) | Uso del acido boswellico y sus derivados para la inhibicion de la actividad normal y elevada de la elastasa de leucocitos o de la plasmina. | |
DE69525649D1 (de) | Lamotrigin haltiges arzneimittel | |
GEP20053617B (en) | Bridged Piperazine Derivatives | |
ES2138092T3 (es) | Utilizacion de los derivados de carbostirilo para la obtencion de un medicamento destinado para inhibir la produccion de la interleucina-8. | |
DK0609336T3 (da) | Anvendelse af prostacyclin-derivater til forebyggelse eller behandling af lidelser i mikrocirkulationssystemet ved administ | |
DE69828615D1 (de) | Verwendung von inhibitoren der komplementaktivierung zur herstellung eines medikaments zur inhibierung von nebenwirkungen von pharmazeutischen zusammensetzungen, die amphiphile träger oder wirkstoffträger moleküle enthalten | |
DE60123117D1 (de) | Verwendung von alpha-halogenacryloyl-distamycin derivaten zur herstellung eines medikaments zur behandlung von krebs | |
FR2701260B1 (fr) | Dérivés de 2-[4-(4-azolylbutyl)-1-pipérazinyl]-5-hydroxypyrimidine, leur préparation et leur application en tant que médicaments. | |
IT1284873B1 (it) | Derivati stabili di ubichinolo procedimenti per la loro produzione e loro impiego farmaceutico | |
GB9126874D0 (en) | Medicaments | |
ATE220065T1 (de) | Benzopyranderivate und ihre verwendung zur behandlung von herzkrankheiten | |
ATE190845T1 (de) | Rektale flunisolid-zubereitung zur behandlung entzündlicher darmerkrankungen | |
ATE300304T1 (de) | Verwendung von xanthinederivaten zur herstellung eines arzneimittels zur behandlung oder verhütung von osteoporose | |
PT1165596E (pt) | Derivados de 14,15-alfa-metileno equilenina processos para producao dos mesmos e medicamentos que os contem | |
HUP0200148A2 (hu) | N-(3',4'-dimetoxi-cinnamoil)antranilsav alkalmazása szívkoszorúér-műtéttel kapcsolatos cardiovascularis események megelőzésére vagy mérséklésére | |
DE69429538D1 (de) | Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 6 infektionen | |
HUP0200129A2 (hu) | N-(3'4'-dimetoxi-cinnamoil)-antranilsav alkalmazása szívkoszorúér-műtéttel kapcsolatos cardiovascularis események megelőzésére vagy mérséklésére |